The Society for Immunotherapy of Cancer (SITC) has selected Michael B. Atkins, MD, deputy director of Georgetown Lombardi, as recipient of its 2022 SITC Lifetime Achievement Award. The honor recognizes those who have demonstrated a lifelong commitment to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. A physician-scientist, Atkins is an internationally recognized leader in translational and clinical research with a focus on immunotherapy for melanoma and renal cell carcinoma, and biomarkers for response and toxicity. He has published over 500 original research and review articles and five books and has lectured extensively on these topics. Atkins is past president of the Society for Immunotherapy of Cancer.

The inaugural BellRinger weekend is just around the corner, October 21-22. Learn more about this ride at a kickoff lunch. All are welcome to attend! Please register online to attend the lunch. The first 50 people to arrive will receive a commemorative BellRinger22 T-shirt.

On Thursday, September 15 from 6:00 to 9:00 p.m. (VIP entrance starts at 5 p.m.) join the Friends of Lombardi for the Fourth Annual Lombardi Live concert featuring White Ford Bronco, to benefit Georgetown Lombardi. The event takes place at The Bullpen (1201 Half Street SE, Washington, DC). Friends of Lombardi is a network of young professionals throughout the DC region with a primary focus to support Georgetown Lombardi’s mission. View more information and purchase tickets.

Joseph Wu, MD, PhD, director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, professor of medicine and radiology, Stanford University School of Medicine, presents “Stem Cells & Genomics for Precision Medicine.” Sponsored by the Office of the Dean for Research. Join this seminar via Zoom.

Binfeng Lu, PhD, director of the Center for Discovery and Innovation of Hackensack Meridian Health and Georgetown Lombardi member, presents “Tissue Alarmin Cytokines as a Novel Cancer Immunotherapy.” Join this lecture via Zoom.

“Cutaneous Hypertrophic Scarring: Pathophysiology, Putative Mechanisms, and Potential Therapies” will be presented by Jeffrey Shupp, MD, director, Burn Center, chief of burn surgery, MedStar Washington Hospital Center, lead investigator, Firefighters' Burn and Surgical Research Laboratory, director of burn research, MedStar Health Research Institute, and professor of surgery, plastic surgery, and biochemistry and molecular and cellular biology, Georgetown. Sponsored by MedStar Health Research Institute and GHUCCTS. Join the Grand Rounds via Zoom.

Stephen Auvil, Chief Program Operations Officer, Maryland Technology Development Corporation (TEDCO), presents “Accessing Resources to Launch Your Start-up.” Sponsored by the Office of Technology Commercialization. Register to join this online seminar. 

REKS faculty members present “Ethics, Equity, and Research Protections for Un/underinsured Participants” as the final webinar in this series highlighting innovative community research and regulatory requirements, and their ethical implications. Sponsored by GHUCCTS. Register for this webinar.

Save the date for the 13th Annual Ruesch Center Symposium: Nov 18-19, 2022! Sign up to receive more information about the agenda and speakers.

ABC 7 News BellRinger's Fight Against Cancer

PoPville White Ford Bronco Concert Benefiting Georgetown Lombardi Comprehensive Cancer Center

PRWeb Society for Immunotherapy of Cancer Announces Annual Award Recipients

Applications are being accepted for the Lung Cancer Foundation of America - Bristol-Myers Squibb/ILCF Young Investigator Research Awards in Translational Immuno-oncology. The objective of these awards is to support research in translational immuno-oncology, undertaken by early career investigators from under-represented populations and underfunded institutions, that aims to improve the care and treatment of individuals with lung cancers and other thoracic malignancies. Two grants will be awarded, the Young Investigator Disparities in Clinical Oncology Research Fellowship and the Young Investigator Diversity and Inclusion in Clinical Oncology Research Fellowship, each worth $200,000 over two years. Note: Applicants must be a member of the IASLC. Applications will be accepted through August 31. View more information and apply.

Meetings in italics should be attended by all fellows.

9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)

12:15 PM | Metastatic Colon Cancer - Dr. Weinberg | Podium A / Zoom

4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)

5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)

8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)

9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Microsoft Teams

12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams

12:15 PM | Small Cell Lung Cancer - Dr. Liu | Podium A / Zoom

5:00 PM | GI Tumor Board | Podium A / Microsoft Teams

9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams

12:15 PM | Heme Path - Dr. Ozdermirli | Podium A / Zoom

12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)

5:00 PM | Lymphoma Tumor Board - Biweekly | Microsoft Teams

7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)

12:00 PM | No Lecture

1:00 PM | Pancreas Tumor Board | Microsoft Teams